[144] CoreWeave, Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 filed for CoreWeave, Inc. (CRWV) reports proposed insider sales and recent 10b5-1 transactions. The notice lists a proposed sale of 250,000 common shares through Morgan Stanley Smith Barney with an aggregate market value of $30,117,500, to be sold on or about 09/16/2025 on NASDAQ. The shares were acquired as founders shares on 11/13/2017. The filing also discloses multiple recent 10b5-1 sales by Brannin McBee and the Brannin J. McBee 2022 IRR Trust, including several blocks of 250,000 and 375,000 shares sold in August and September 2025, with gross proceeds listed for each trade. The filer certifies no undisclosed material adverse information and references reliance on Rule 10b5-1 trading plans where applicable.

Positive

• Disclosure of large insider sales through Rule 144 and multiple 10b5-1 trades provides transparency to the market
• Use of a broker (Morgan Stanley Smith Barney) and stated reliance on Rule 10b5-1 suggests trades are transacted via established procedures

Negative

• Large share dispositions (multiple 250,000 and 375,000-share blocks) could increase supply pressure on the stock in the short term
• Plan adoption date not provided in the visible content, limiting confirmation that all trades were pre-scheduled under 10b5-1 controls

Insights

Securities Analyst

TL;DR: Insider selling under Rule 144 and multiple 10b5-1 sales show meaningful share disposition by related parties.

The filing documents a proposed Rule 144 sale of 250,000 founder shares valued at about $30.1 million and a string of recent 10b5-1 transactions by Brannin McBee and an associated trust selling 250,000 and 375,000 share blocks across August and September 2025 with substantial gross proceeds. These disclosures are routine for insiders monetizing positions but are material in size relative to the single reported outstanding share count of 370,470,348 shown in the form. For investors, the key implications are transparency around timing and method of sales and confirmation that transactions were executed through trading plans or broker channels; no new operational or financial metrics are provided in this filing.

Corporate Governance Expert

TL;DR: The filing is a standard insider notice confirming compliance with Rule 144 and 10b5-1 procedures.

The document indicates the seller acquired the shares as founders shares in 2017 and is using established broker channels and 10b5-1 plans to effect sales. The representation that the signer is unaware of undisclosed material adverse information is standard and the form includes explicit attention to the 10b5-1 plan adoption date field, though that date is not shown in the content provided. From a governance perspective, the transparency is appropriate; however, absence of the plan adoption date in the visible content limits assessment of whether trades align strictly with pre-established plans.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	250000	30117500.00	370470348	09/16/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/13/2017	Founders Shares	Issuer			250000	11/13/2017	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for BRANNIN MCBEE 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	09/09/2025	250000	24866825.00
10b5-1 Sales for BRANNIN J. MCBEE 2022 IRR TRUST 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	09/09/2025	375000	37301250.00
10b5-1 Sales for BRANNIN MCBEE 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	09/02/2025	250000	23292325.00
10b5-1 Sales for BRANNIN J. MCBEE 2022 IRR TRUST 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	09/02/2025	375000	34938487.50
10b5-1 Sales for BRANNIN MCBEE 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	08/26/2025	250000	22996925.00
10b5-1 Sales for BRANNIN J. MCBEE 2022 IRR TRUST 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	08/26/2025	375000	34495387.50
10b5-1 Sales for BRANNIN MCBEE 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	08/19/2025	250000	22926475.00
10b5-1 Sales for BRANNIN J. MCBEE 2022 IRR TRUST 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	08/19/2025	375000	34389712.50

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for CoreWeave (CRWV) disclose?

The filing discloses a proposed sale of 250,000 common shares valued at $30,117,500 to be sold on or about 09/16/2025, plus several recent 10b5-1 sales by related parties in Aug–Sep 2025.

Who is selling shares according to the filing?

The securities are linked to founders shares and recent 10b5-1 sales by Brannin McBee and the Brannin J. McBee 2022 IRR Trust as listed in the form.

How many shares outstanding does the form report?

The filing shows 370,470,348 shares outstanding for the issuer in the securities table.

What broker is handling the proposed sale?

The proposed sale lists Morgan Stanley Smith Barney LLC as the broker and indicates the sale is planned on NASDAQ.

Were the shares originally acquired as part of a founder grant?

Yes, the securities to be sold were acquired as Founders Shares on 11/13/2017 from the issuer.

Do the sellers represent there is undisclosed material information?

By signing the notice, the person represents they do not know any material adverse information not publicly disclosed.